(Q37972941)

26 August 2017

title

Current insulin analogues in the treatment of diabetes: emphasis on type 2 diabetes (English)

1 reference

26 August 2017

0 references

1 reference

Katherine Esposito

1

1 reference

26 August 2017

Dario Giugliano

series ordinal

2

1 reference

26 August 2017

language of work or name

English

0 references

publication date

4 January 2012

1 reference

Expert Opinion on Biological Therapy

26 August 2017

published in

1 reference

26 August 2017

volume

12

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

209-221

1 reference

Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Standards of medical care in diabetes--2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Is glycemic control improving in U.S. adults?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Barriers to insulin initiation: the translating research into action for diabetes insulin starts project

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

New insulins and new insulin regimens: a review of their role in improving glycaemic control in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: improvements and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Use of lispro insulin and quality of life in adolescents on intensive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Systematic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Pharmacokinetics and pharmacodynamics of insulin lispro protamine suspension compared with insulin glargine and insulin detemir in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Does diabetes therapy influence the risk of cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Insulin and its analogs: actions via insulin and IGF receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Insulin therapy in diabetes and cancer risk: current understanding and implications for future study: proceedings from a meeting of a European Insulin Safety Consensus Panel, convened and sponsored by Novo Nordisk, held Tuesday October 5, 2010 at Th

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Controversies in the use of insulin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Insulin analogues and their potential in the management of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Meta-analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Pharmacokinetics and pharmacodynamics of therapeutic doses of basal insulins NPH, glargine, and detemir after 1 week of daily administration at bedtime in type 2 diabetic subjects: a randomized cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Differential effects of adiposity on pharmacodynamics of basal insulins NPH, glargine, and detemir in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

A randomized, treat-to-target trial comparing insulin lispro protamine suspension and insulin detemir in insulin-naive patients with Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Three-year efficacy of complex insulin regimens in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Efficacy of insulin analogs in achieving the hemoglobin A1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Increase of body weight during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Pivotal role of timely basal insulin replacement after metformin failure in sustaining long-term blood glucose control at a target in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Insulin: potential negative consequences of early routine use in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Glucose control and vascular complications in veterans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Post hoc subgroup analysis of the HEART2D trial demonstrates lower cardiovascular risk in older patients targeting postprandial versus fasting/premeal glycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

A new-generation ultra-long-acting basal insulin with a bolus boost compared with insulin glargine in insulin-naive people with type 2 diabetes: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Glucose variability; does it matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Does insulin detemir have a role in reducing risk of insulin-associated weight gain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: a randomized controlled trial in patients with type 2 diabetes beginning insulin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

DURAbility of basal versus lispro mix 75/25 insulin efficacy (DURABLE) trial 24-week results: safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.648181

10.1517/14712598.2012.648181

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference